0001144204-13-010737 Sample Contracts

RESEARCH AND DEVELOPMENT AGREEMENT
Research and Development Agreement • February 22nd, 2013 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York

This Amendment No. 2 to Research and Development Agreement, dated February 15, 2013, is entered into by and between INTERCEPT PHARMACEUTICALS, INC., a corporation organized and existing under the laws of Delaware, with its registered office at 18 Desbrosses Street, New York, NY 10013, USA (“INTERCEPT”) on the one hand and TES Pharma Srl, a corporation organized and existing under the laws of Italy, with its registered office at Via Settevalli 556, 06129, Perugia, Italy (“TES”) on the other hand.

AutoNDA by SimpleDocs
AMENDMENT NO. 2 TO
Consulting and Intellectual Property Agreement • February 22nd, 2013 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York

This Amendment No. 2 to Consulting and Intellectual Property (“IP”) Agreement (this “Amendment”), dated February 15, 2013, is entered into by and between INTERCEPT PHARMACEUTICALS, INC., a corporation organized and existing under the laws of Delaware, with its registered office at 18 Desbrosses Street, New York, NY 10013, USA (“INTERCEPT”) on the one hand and ROBERTO PELLICCIARI (“Consultant”), residing at Via U. Rocchi, 60, Perugia, Italy 06123, on the other hand:

AMENDMENT N°2 TO PRODUCT RESEARCH, DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT (this “Amendment”)
Product Research, Development, License and Commercialization Agreement • February 22nd, 2013 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations

a corporation organized and existing under the laws of Delaware, with registered office at 18 Desbrosses Street, New York, NY 10013, USA

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!